You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Express Scripts
McKinsey
Dow
Johnson and Johnson

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)

Docket   Start Trial Date Filed 2015-08-06
Court District Court, D. New Jersey Date Terminated 2017-10-27
Cause 35:271 Patent Infringement Assigned To Renee Marie Bumb
Jury Demand None Referred To Karen M. Williams
Parties AGILA SPECIALTIES, INC; ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP; ASTRAZENECA UK LIMITED; INNOPHARMA LICENSING LLC; MYLAN INC.; MYLAN INSTITUTIONAL LLC; MYLAN LABORATORIES LIMITED; MYLAN PHARMACEUTICALS INC.; ONCO THERAPIES LIMITED; TEVA PHARMACEUTICALS USA, INC.
Patents 4,659,516; 6,417,191; 6,774,122; 7,456,160; 8,329,680; 8,466,139
Attorneys ALLISON LINDA HOLLOWS; ARNOLD B. CALMANN; CAITLIN P. HOGAN; CAROLYN SUZANNE WALL; CHRISTOPHER ROBERT KINKADE; GUILLERMO CARLO ARTILES; JEFFREY S. SOOS; JOHN EDMUND FLAHERTY; KAREN A. CONFOY; KATHERINE ANN ESCANLAR; MAYRA VELEZ TARANTINO; MICHAEL E. PATUNAS; RAVIN R. PATEL; STEVEN J. DAROCI; STEVEN JAMES LINK
Firms Fox Rothschild LLP; Fox Rothschild LLP, Pc; McCarter and English, LLP; O'Melveny & Myers LLP; Patunas Law LLC; Patunas Tarantino LLC
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for ASTRAZENECA PHARMACEUTICALS LP v. AGILA SPECIALTIES, INC (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-09-21 10 THE PATENTS-IN-SUIT 26. United States Patent No. 6,774,122 (the “’122 Patent”), entitled… the expiration of AstraZeneca’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. … COUNT I: INFRINGEMENT OF U.S. PATENT NO. 6,774,122 40. Plaintiffs hereby reallege… U.S. PATENT NO. 6,774,122 51. Plaintiffs hereby reallege… This is a civil action for patent infringement under the patent laws of the United States, Title External link to document
2016-09-02 120 Compendium of Excipients for • U.S. Patent No. 4,659,516, AZF00716989–7010 …Statement for U.S. Patent Nos. 6,774,122 (“the ’122 Patent”), 7,456,160 (“the ’160 Patent”), 8,329,680 (… (“the ’680 Patent”), and 8,466,139 (“the ’139 Patent”) (collectively, “the Patents-in-Suit”) in the…disputed term in the ’122 Patent (Exhibit A), the ’160 Patent (Exhibit B), the ’680 Patent (Exhibit C), and…these Hatch-Waxman patent actions, Plaintiffs are asserting infringement of the Patents-in-Suit against External link to document
2017-01-05 197 enjoined from infringing United States Patent Numbers 6,774,122, 7,456,160, 8,329,680 and 8,466,139, on…2015 27 October 2017 1:15-cv-06039 830 Patent None District Court, D. New Jersey External link to document
2015-12-08 29 the expiration of the Plaintiff’s U.S. Patent Nos. 6,774,122, 7,456,160, 8,329,680, and 8,466,139. …law and fact in so much as they are actions for patent infringement Case 1:15-cv-06039-RMB-KMW Document…2015 27 October 2017 1:15-cv-06039 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
McKinsey
Express Scripts
Baxter
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.